Issues
Volume 215 Issue 6
News
News briefs
High blood pressure rates have doubled to more than 1.2 billion Over the past 30 years, the number of adults (aged 30–79 years) living with hypertension worldwide has doubled — rising from an estimated 331 million women and 317 million men in 1990, to 626 million women and 652 million men in 2019, with most of this increase occurring in low and middle income countries. The international study, published in The Lancet, analysed blood pressure measurements from more than 100 million people taken over three decades in 184 countries. Nearly half of people (41% of women and 51% of men) with hypertension worldwide in 2019 were unaware of their condition; and more than half of women (53%) and men (62%) with the condition were not treated. Worldwide, blood pressure was controlled (ie, medicines were effective in bringing blood pressure to normal ranges) in fewer than 1 in 4 women and 1 in 5 men with hypertension. The Non‐Communicable Disease Risk Factor Collaboration analysed data from 1201 population‐representative studies, involving 104 million people from 184 countries (covering 99% of the world’s population). The authors only used data from studies that had measured blood pressure, to avoid biases in self‐reported data. Hypertension was defined as having systolic blood pressure of ≥ 140 mmHg, diastolic blood pressure of ≥ 90 mmHg, or taking medication for high blood pressure. Modelling was used to estimate prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis, who were taking medication for hypertension, and whose hypertension was controlled to below 140/90 mmHg, by country, year and age. The authors noted that while the study provides the first comparable estimates of blood pressure prevalence, diagnosis, treatment and control in adults for all countries of the world, it may be affected by a lack of data in some countries, especially in Oceania and sub‐Saharan Africa. https://www.thelancet.com/journals/lancet/article/piiS0140-6736(21)01330-1/fulltext COVID‐19 infection linked to higher blood clot risk after surgery Research published in Anaesthesia shows that venous thromboembolisms (VTEs), a known complication of surgery, are 50% more likely to occur in patients with current COVID‐19 and almost twice as likely in those with recent COVID‐19. The study also found having a VTE was associated with a five‐time increased risk of death within 30 days following surgery compared with patients with no VTE. Patients were categorised as having VTE (pulmonary embolism or deep vein thrombosis) within 30 days of surgery. COVID‐19 diagnosis was defined as peri‐operative (7 days before to 30 days after surgery); recent (1–6 weeks before surgery); previous (7 weeks or more before surgery); or no diagnosis past or present. The postoperative VTE rate was 0.5% (666/123 591) in patients without COVID‐19; 2.2% (50/2317) in patients with peri‐operative COVID‐19; 1.6% (15/953) in patients with recent COVID‐19; and 1.0% (11/1148) in patients with previous COVID‐19. After adjustment for confounding factors, patients with peri‐operative COVID‐19 had a 50% higher risk of VTE and those with recent COVID‐19 had a 90% increased risk. Patients with previous COVID‐19 had a 70% increased risk of VTE, but this result was of borderline statistical significance. Overall, VTE was independently associated with 30‐day mortality, increasing the risk of death during this period by 5.4 times. In patients with COVID‐19, mortality without VTE was 7.4% (319/4342), and with VTE, was again more than five times higher at 40.8% (31/76). The authors concluded: “Routine postoperative care of surgical patients should include interventions to reduce VTE risk in general, and further research is needed to define the best protocols for VTE prevention and treatment in this setting.” https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/anae.15563
Perspectives
Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia
VITT is a potential complication of ChAdOx1-nCov-19 vaccination — early recognition is key to improved outcomes
Vivien M Chen · Jennifer L Curnow · Huyen A Tran · Philip Y‐I Choi
Why we should and how we can increase medical school admissions for persons with disabilities
Medical students with disabilities bring lived experience as patients, with a positive impact on school culture and learning
Liz Fitzmaurice · Kenneth Donald · Carl Wet · Dinesh Palipana
Placebos in clinical care: a suggestion beyond the evidence
The recent enthusiasm for the clinical use of placebos seems driven by myths and misunderstandings
Christopher G Maher · Adrian C Traeger · Christina Abdel Shaheed · Mary O'Keeffe
Medical education
Paroxysmal nocturnal haemoglobinuria: an easily missed entity
A 27-year-old man presented with right upper quadrant abdominal pain which had gradually worsened in the previous week
Muhajir Mohamed · Jeanette Koay
Methaemoglobinaemia associated with the atypical use of sodium nitrite as a food additive
A public health unit in Sydney was notified of two unrelated patients who presented on the previous day with methaemoglobinaemia
Caitlin O’Neill · Zeina Najjar · Andrew Ingleton · Alan Edwards · Andrew Dawson · Leena Gupta
Giant atrial myxoma leading to stroke
A previously healthy 45-year-old woman presented with a history of sudden-onset right hemiparesis and dysarthria while walking
Mário LM Silva Júnior · Tereza EFC Albuquerque · Eduardo S Melo
Erratum
Erratum
Allard NL, MacLachlan JH, Tran L, et al. Time for universal hepatitis B screening for Australian adults. Med J Aust 2021; 215: 103‐105.e1. https://doi.org/10.5694/mja2.51114. In this Perspective article, in the Box on page 104, the colour blue in the legend should read, “Number of people with chronic hepatitis B diagnosed (modelled)”, and the red colour should read, “Number of people with chronic hepatitis B undiagnosed (modelled).”
Editorial
Drug‐induced liver injury caused by herbal and dietary supplements: where to next?
Collaboration and education are critical to understanding and managing this mounting public health problem
Elliot Freeman · Stuart K Roberts
Research
Drug‐induced liver injury in Australia, 2009–2020: the increasing proportion of non‐paracetamol cases linked with herbal and dietary supplements
Objective: To compare the characteristics and outcomes of drug‐induced liver injury (DILI) caused by paracetamol and non‐paracetamol medications, particularly herbal and dietary supplements. Design: Retrospective electronic medical record data analysis. Setting, participants: Adults admitted with DILI to the Gastroenterology and Liver Centre at the Royal Prince Alfred Hospital, Sydney (a quaternary referral liver transplantation centre), 2009–2020. Main outcome measures: 90‐day transplant‐free survival; drugs implicated as causal agents in DILI. Results: A total of 115 patients with paracetamol‐related DILI and 69 with non‐paracetamol DILI were admitted to our centre. The most frequently implicated non‐paracetamol medications were antibiotics (19, 28%), herbal and dietary supplements (15, 22%), anti‐tuberculosis medications (six, 9%), and anti‐cancer medications (five, 7%). The number of non‐paracetamol DILI admissions was similar across the study period, but the proportion linked with herbal and dietary supplements increased from 2 of 13 (15%) during 2009–11 to 9 of 19 (47%) during 2018–20 (linear trend: P = 0.011). Despite higher median baseline model for end‐stage liver disease (MELD) scores, 90‐day transplant‐free survival for patients with paracetamol‐related DILI was higher than for patients with non‐paracetamol DILI (86%; 95% CI, 79–93% v 71%; 95% CI, 60–82%) and herbal and dietary supplement‐related cases (59%; 95% CI, 34–85%). MELD score was an independent predictor of poorer 90‐day transplant‐free survival in both paracetamol‐related (per point increase: adjusted hazard ratio [aHR], 1.19; 95% CI, 1.09–3.74) and non‐paracetamol DILI (aHR, 1.24; 95% CI, 1.14–1.36). Conclusion: In our single centre study, the proportion of cases of people hospitalised with DILI linked with herbal and dietary supplements has increased since 2009. Ninety‐day transplant‐free survival for patients with non‐paracetamol DILI, especially those with supplement‐related DILI, is poorer than for those with paracetamol‐related DILI.
Emily Nash · Abdul‐Hamid Sabih · John Chetwood · Georgette Wood · Keval Pandya · Terry Yip · Avik Majumdar · Geoffrey W McCaughan · Simone I Strasser · Ken Liu
The effects on mortality and the associated financial costs of wood heater pollution in a regional Australian city
The substantial mortality and financial cost means that effective policies are needed to reduce wood heater pollution
Dorothy L Robinson · Joshua A Horsley · Fay H. Johnston · Geoffrey G Morgan
Adding saliva testing to oropharyngeal and deep nasal swab testing increases PCR detection of SARS‐CoV‐2 in primary care and children
Saliva may be suitable as a stand-alone test specimen for people aged 10 years or more
Jane Oliver · Shidan Tosif · Lai‐yang Lee · Anna‐Maria Costa · Chelsea Bartel · Katherine Last · Vanessa Clifford · Andrew Daley · Nicole Allard · Catherine Orr · Ashley Nind · Karyn Alexander · Niamh Meagher · Michelle Sait · Susan A Ballard · Eloise Williams · Katherine Bond · Deborah A Williamson · Nigel W Crawford · Katherine B Gibney
Research letter
The incidence of cardiac complications in patients hospitalised with COVID‐19 in Australia: the AUS‐COVID study
Clinical cardiac complications were reassuringly uncommon among more than 600 patients admitted to hospital with COVID-19
on behalf of the AUS‐COVID Investigators
Narrative review
Interventional bronchoscopy for chronic obstructive pulmonary disease: more than a pipe dream
COPD is the fifth greatest contributor to burden of disease and fifth overall cause of death among Australians
Alan M Carew · Jonathan P Williamson · Claude S Farah · Tajalli Saghaie · Martin Phillips · Alvin Ing
Letters
A hospital‐wide response to multiple outbreaks of COVID‐19 in health care workers: lessons learned from the field
To the Editor: We congratulate Buising and colleagues1 on their article published in the MJA and agree that the approach needs to be multidimensional and iterative. To expand upon the multidimensional theme of their article, we would like to emphasise the need for the approach to be multidisciplinary and to include the whole of the health service workforce. The article highlighted the ubiquitous nature of coronavirus disease 2019 (COVID‐19) transmission in health care settings, with 18.3% (or almost one in five) of health care workers infected, and that these workers are traditionally regarded as non‐clinical staff (food services, environmental services, administrative and security staff). The non‐clinician workforce has been overlooked in other research investigating COVID‐19 transmission risk factors.2 At Monash Health, we used multidisciplinary shift briefings to ensure all health service team members were included in the information and safety messages.3 Human factor‐designed briefing cards, based on the airline industry pre‐flight safety cards, were used to ensure consistent messaging (Box and online Supporting Information). The early involvement of a design team, from the Design Health Collab at Monash University, ensured clear and unambiguous messaging to health care workers. The images were designed to represent diversity in gender, race and role to ensure all health care workers would see themselves reflected in the briefing card and that the safety messages were relevant and directed towards them. Providing information that is timely and accessible as well as readable and visually clear is important.4 Commentaries have emphasised the need for clear and concise communication to ensure the safety and wellbeing of health care workers during the COVID‐19 pandemic.5 However, we believe that involving all workers, not just clinicians, in the safety messages and interventions is paramount to the health and safety of non‐clinical health care workers and to the ongoing operation of health care services. COVID‐19 does not recognise the individual worker role in the health care service and the pandemic has offered us a unique and powerful opportunity to bring together the whole health care workforce and break down traditional barriers. We believe that a multidisciplinary approach is just as vital as a multidimensional one. Box – Card used to ensure consistent messaging during shift briefings Permission to reproduce this image was obtained from the American Journal of Infection Control.
Diana Egerton-Warburton · Lisa Kuhn · Daphne Flynn
We need a model of health and aged care services that adequately supports Australians with dementia
To the Editor: Low and colleagues1 highlight the long‐standing issue that the provision of residential aged care in Australia remains grossly inadequate. This is particularly egregious given that these deficits and remedial actions have been known for decades from numerous inquiries commissioned by successive federal governments and reiterated by the Royal Commission. This vacuum is being filled by initiatives undertaken by the Victorian Government in public sector residential aged care services to develop better ways to conceptualise aged care. We acknowledge there is no single ideal model2 for the provision of residential aged care, as there is such wide variation in residential aged care services profiles (eg, number and type of residents, geographic location, physical environment, staffing). However, our recently proposed conceptual model for the provision of residential aged care3 includes many of the necessary aspects recommended by the NHMRC National Institute for Dementia Research Special Interest Group in Rehabilitation and Dementia. Our conceptual model takes as its purpose the provision of person‐centred care to older people with complex health issues, especially those living with dementia. It consists of five domains relevant to the experience of older people living in residential aged care: health care, social inclusion, individual rights, personal care and reablement, and dementia management. The model also supports the dignity of risk and quality of life beyond clinical care to enable older people to thrive. The development of our model involved several stages using a similar approach to model development described in 20104 which comprised: initial conceptualisation and development based on a review of the literature to document and map the key domains of residents’ needs in aged care; brainstorming using the expertise and experience of the research team to refine and categorise the domains and subdomains; extensive consultation with key stakeholders (n = 382) to test the model for feasibility and acceptability (field testing) for the sector; and testing against a range of theoretical organisational failure scenarios (validity checks against coroners’ cases). The model has been presented to the Royal Commission into Aged Care Quality and Safety and published in a peer‐reviewed journal.3 Uptake of this model would allow the Commonwealth government, which finances and regulates this sector, and individual service providers to have a common understanding of aged care. This is an important step towards improving aged care services.
Jo‐Anne Rayner · Deirdre Fetherstonhaugh · Joseph E Ibrahim
South Australian experience with paediatric total pancreatectomy and islet autotransplantation for PRSS1‐associated hereditary pancreatitis
Jessica Eldredge · Michael R Couper · David J Moore · Sanjeev Khurana · John WC Chen · Jennifer J Couper · Christopher J Drogemuller · Toni Radford · Thomas W Kay · Tom Loudovaris · Michael Wilks · Patrick T Coates · Richard TL Couper
Collaborative Commissioning: regional funding models to support value‐based care in New South Wales
Elizabeth Koff · Susan Pearce · David P Peiris
Reforming our health care system: time to rip off the band‐aid?
Claire L Jackson · Diana O’Halloran
Regulating complementary, unconventional and emerging treatments in Australia: a missed opportunity
Miriam Wiersma · Ian H Kerridge · Cameron L Stewart · Wendy L Lipworth
Updated Australian guidance for health care providers about “undetectable = untransmittable” for HIV
James H McMahon · Brent Allan · Daniel Grace · Nic Holas
Medico‐legal risks associated with fragmented care in general practice
Jack Marjot · Georgie Haysom · Penny Browne